US Patent Application No: 2005/0208,141

Number of patents in Portfolio can not be more than 2000

Delivery systems for functional ingredients

Stats

ALSO PUBLISHED AS: 7531192
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

The present invention provides oral delivery systems for functional ingredients, such as drugs, nutritional supplements, botanicals, and vitamins. The delivery systems comprise an ingestible matrix within which the functional ingredient(s) are substantially uniformly and completely dispersed and in which degradation of the functional ingredient(s) is minimised. The matrix comprises 1) one or more carbohydrate; 2) one or more sugar, sugar syrup and/or sugar alcohol; 3) one or more hydrocolloid; 4) one or more polyhydric alcohol; 5) one or more source of mono- or divalent cations, and 5) water. The combination of carbohydrate and hydrocolloid in the matrix ensures that the delivery system readily retains the solvent component and thereby prevents separation of the solvent from other components of the matrix. The invention also provides methods of preparing and using the delivery systems.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
2120812 ONTARIO INC.TORONTO ONTARIO, CA3

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Farber, Jonathan Montreal, CA 9 47
Farber, Michael Wolfratshausen, DE 29 186

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
FUJIFILM MANUFACTURING EUROPE B.V. (7)
8,357,397 Controlled release composition comprising a recombinant gelatin 0 2008
8,349,588 Recombinant XRGD-enriched gelatins having high stability 0 2008
8,349,589 Non-natural recombinant gelatins with enhanced functionality 0 2008
8,198,047 RGD containing recombinant gelatin 0 2008
8,158,756 Recombinant gelatins 0 2008
8,101,205 Controlled release composition 2 2008
8,173,776 Recombinant gelatins 0 2011
 
BARR LABORATORIES, INC. (2)
7,390,503 Ondansetron orally disintegrating tablets 0 2004
7,811,604 Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same 0 2006
 
2120812 ONTARIO INC. (1)
7,067,150 Delivery systems for functional ingredients 9 2003
 
FAGRON, INC. (1)
8,021,682 Palatable suspending vehicle for pharmaceutical ingredients 0 2005
 
MCCORMICK & COMPANY, INC. (1)
7,488,503 Encapsulation compositions and processes for preparing the same 3 2004
 
WATSON LABORATORIES, INC. (1)
7,838,029 Mirtazapine solid dosage forms 0 2004